The CD4 + Tfh cell, the malignant driver of AITL highly expresses surface markers such as CD4, CXCR5, PD-1, ICOS and CD40L that determine its Tfh-like phenotype [16]. This evidence concerns the gene ICOS and angioimmunoblastic T-cell lymphoma.